GB9807114D0 - Novel process - Google Patents

Novel process

Info

Publication number
GB9807114D0
GB9807114D0 GBGB9807114.5A GB9807114A GB9807114D0 GB 9807114 D0 GB9807114 D0 GB 9807114D0 GB 9807114 A GB9807114 A GB 9807114A GB 9807114 D0 GB9807114 D0 GB 9807114D0
Authority
GB
United Kingdom
Prior art keywords
novel process
penciclovir
famciclovir
ethenyl
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9807114.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9807114.5A priority Critical patent/GB9807114D0/en
Publication of GB9807114D0 publication Critical patent/GB9807114D0/en
Priority to BR9908964-5A priority patent/BR9908964A/pt
Priority to HK01105015.9A priority patent/HK1034512B/en
Priority to KR1020007010707A priority patent/KR100701114B1/ko
Priority to ES99915738T priority patent/ES2247793T3/es
Priority to CNB998044008A priority patent/CN1153769C/zh
Priority to IL13828899A priority patent/IL138288A/xx
Priority to US09/623,662 priority patent/US6555685B1/en
Priority to PCT/EP1999/002308 priority patent/WO1999051603A1/en
Priority to AT99915738T priority patent/ATE304541T1/de
Priority to DE69927251T priority patent/DE69927251T2/de
Priority to AU34200/99A priority patent/AU3420099A/en
Priority to EP99915738A priority patent/EP1068209B1/en
Priority to CA002322583A priority patent/CA2322583A1/en
Priority to JP2000542324A priority patent/JP4524040B2/ja
Priority to DK99915738T priority patent/DK1068209T3/da
Priority to US10/369,841 priority patent/US6806375B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
GBGB9807114.5A 1998-04-02 1998-04-02 Novel process Ceased GB9807114D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9807114.5A GB9807114D0 (en) 1998-04-02 1998-04-02 Novel process
DK99915738T DK1068209T3 (da) 1998-04-02 1999-03-30 Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter
PCT/EP1999/002308 WO1999051603A1 (en) 1998-04-02 1999-03-30 Process for the production of purine derivatives and intermediates therefor
DE69927251T DE69927251T2 (de) 1998-04-02 1999-03-30 Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte
KR1020007010707A KR100701114B1 (ko) 1998-04-02 1999-03-30 푸린 유도체 및 이를 위한 중간체를 제조하는 방법
ES99915738T ES2247793T3 (es) 1998-04-02 1999-03-30 Procedimiento para la produccion de derivados de purina y compuestos intermedios para ello.
CNB998044008A CN1153769C (zh) 1998-04-02 1999-03-30 嘌呤衍生物及其中间体以及该衍生物的制备方法
IL13828899A IL138288A (en) 1998-04-02 1999-03-30 2-amino-9-[bisetherified 4-hydroxy-3-(hydroxymethyl) butyl] purine derivatives, process for the production thereof, intermediates therefor and their use as starting materials for the preparation of antiviral purines
US09/623,662 US6555685B1 (en) 1998-04-02 1999-03-30 Process for the production of purine derivatives and intermediates therefor
BR9908964-5A BR9908964A (pt) 1998-04-02 1999-03-30 Processo para produção de derivados de purina e intermediários para os mesmos
AT99915738T ATE304541T1 (de) 1998-04-02 1999-03-30 Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte
HK01105015.9A HK1034512B (en) 1998-04-02 1999-03-30 Process for the production of purine derivatives and intermediates therefor
AU34200/99A AU3420099A (en) 1998-04-02 1999-03-30 Process for the production of purine derivatives and intermediates therefor
EP99915738A EP1068209B1 (en) 1998-04-02 1999-03-30 Process for the production of purine derivatives and intermediates therefor
CA002322583A CA2322583A1 (en) 1998-04-02 1999-03-30 Process for the production of purine derivatives and intermediates therefor
JP2000542324A JP4524040B2 (ja) 1998-04-02 1999-03-30 プリン誘導体の製法およびその中間体
US10/369,841 US6806375B2 (en) 1998-04-02 2003-02-19 Process for the production of purine derivatives and intermediates therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807114.5A GB9807114D0 (en) 1998-04-02 1998-04-02 Novel process

Publications (1)

Publication Number Publication Date
GB9807114D0 true GB9807114D0 (en) 1998-06-03

Family

ID=10829763

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9807114.5A Ceased GB9807114D0 (en) 1998-04-02 1998-04-02 Novel process

Country Status (15)

Country Link
US (2) US6555685B1 (https=)
EP (1) EP1068209B1 (https=)
JP (1) JP4524040B2 (https=)
KR (1) KR100701114B1 (https=)
CN (1) CN1153769C (https=)
AT (1) ATE304541T1 (https=)
AU (1) AU3420099A (https=)
BR (1) BR9908964A (https=)
CA (1) CA2322583A1 (https=)
DE (1) DE69927251T2 (https=)
DK (1) DK1068209T3 (https=)
ES (1) ES2247793T3 (https=)
GB (1) GB9807114D0 (https=)
IL (1) IL138288A (https=)
WO (1) WO1999051603A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60202245T2 (de) 2001-08-30 2005-09-01 Ajinomoto Co., Inc. Herstellungsmethode von Famciclovir und Herstellungs- bzw. Kristallisationsmethode eines entsprechenden Intermediates
AU2003268213A1 (en) * 2002-08-26 2004-03-11 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
CA2522573A1 (en) * 2003-04-30 2004-11-18 Teva Pharmaceutical Industries Ltd. Process for the preparation of famciclovir
EP1556383A1 (en) * 2003-09-04 2005-07-27 Teva Pharmaceutical Industries Ltd. Process for preparing famciclovir
WO2005103025A1 (en) * 2004-04-21 2005-11-03 Novogen Research Pty Ltd Isoflavene synthetic method and catalyst
GB2426247A (en) * 2005-05-20 2006-11-22 Arrow Int Ltd Methods of preparing purine derivatives such as famciclovir
DK2609083T3 (da) 2010-08-27 2015-03-30 Gruenenthal Gmbh Substituerede 2-oxy-quinolin-3-carboxamider som KCNQ2/3 modulatorer
SI2609086T1 (sl) 2010-08-27 2015-04-30 Gruenenthal Gmbh Substituirani 2-okso in 2-tiokso-dihidrokinolin-3-karboksamidi kot KCNQ2/3 modulatorji
TW201211007A (en) 2010-08-27 2012-03-16 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
MX2013002295A (es) 2010-09-01 2013-05-09 Gruenenthal Gmbh 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
CN102070636B (zh) * 2011-01-17 2012-05-23 浙江大学 喷昔洛韦的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73682A (en) 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
JPH06279443A (ja) * 1993-01-27 1994-10-04 Asahi Chem Ind Co Ltd ６’−ホモネプラノシンａ誘導体およびその製造法
GB9407698D0 (en) * 1994-04-19 1994-06-15 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
JP2002510691A (ja) 2002-04-09
IL138288A (en) 2005-07-25
CN1153769C (zh) 2004-06-16
US20030130512A1 (en) 2003-07-10
DE69927251D1 (de) 2005-10-20
ATE304541T1 (de) 2005-09-15
US6555685B1 (en) 2003-04-29
US6806375B2 (en) 2004-10-19
CN1294589A (zh) 2001-05-09
WO1999051603A1 (en) 1999-10-14
ES2247793T3 (es) 2006-03-01
EP1068209B1 (en) 2005-09-14
DK1068209T3 (da) 2005-11-14
BR9908964A (pt) 2000-12-05
KR100701114B1 (ko) 2007-03-29
IL138288A0 (en) 2001-10-31
CA2322583A1 (en) 1999-10-14
AU3420099A (en) 1999-10-25
EP1068209A1 (en) 2001-01-17
JP4524040B2 (ja) 2010-08-11
KR20010034702A (ko) 2001-04-25
DE69927251T2 (de) 2006-06-29
HK1034512A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
WO1999064047A8 (en) Novel antiviral compounds
MY120511A (en) New pesticides
HUP0100779A3 (en) Novel derivatives of 3,3-diphenylpropylamines
ZA99402B (en) Efficient process to produce oxygen.
ID27843A (id) Substitusi 1, 8-naftiridin-4(ih)-on sebagai penghambat fosfodiesterase 4
AU2962800A (en) Pyrrolo(2,3-(d))pyrimidines as antiviral agents
IN2012DE00109A (https=)
MXPA03008811A (es) Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas.
AU5652698A (en) (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
GB9807114D0 (en) Novel process
GB9905848D0 (en) Improvements relating to the cutting of workpieces
MXPA03003923A (es) Compuestos de n-([1,2,4]triazoloazinil)tiofensulfonamida como herbicidas.
EP0569491A4 (en) 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
HUP0003593A3 (en) Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors
IT1302934B1 (it) Composizione per migliorare l'aspetto di getti cementizi.
AU1595997A (en) Thienoxazinone derivatives useful as antiviral agents
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
PL338454A1 (en) Lixofuranosilbenzimidazoles as antiviral agents
GB9806409D0 (en) Processes for preparing intermediates
ZA983231B (en) Substituted benzyloxyimino compounds.
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
CA2328832A1 (en) Processes for preparing pesticidal intermediates
BR9607850A (pt) Processo para a preparação de um composto e composto
BG105624A (en) Process for preparing n6-substituted deaza-adenosine derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)